Clinicians should apply clinical judgement to select an individualised approach and may choose between: A one-to-two-week washout before semaglutide initiation, which is preferred for patients with significant side effects
These conditions include high blood pressure, high cholesterol or Type 2 diabetes
While research has shown promising results in terms of weight reduction, individual health conditions, potential side effects, and the need for a comprehensive approach to weight management , including a balanced diet and regular physical activity is still important
Additionally, it appears safe for most patients without significant side effects or risks associated with long-term use when compared to other treatments such as bariatric surgery or lifestyle interventions alone
Mounjaro is currently supplied as an injection, not a tablet